- Home
- Choose Amundi
- News
News
20 news articles are available
01/08/2017
Global Investment Views - 07-2017
CIO views: High conviction ideas from Amundi Global Investment Committee
01/08/2017
Equity markets: watch out for the swinging doors!
The signal launched by the deterioration in US companies’ margins can for the moment be put into perspective. As long as US 10- year yields remain contained between 2% and 3% and corporate profits improve, which should be the case at least until the autumn given the favourable base effects, the equities cycle can continue.
01/08/2017
Cross Asset Investment Strategy - 07-2017
Find the latest edition of the monthly publication of our Research Team.
20/06/2017
Lessons learned from the Q1 2017 earnings season
As the earnings season comes to a close, the time has come to report back on what we have found.
20/06/2017
Biosimilars – Now a reality even for complex biologics
Within the next five years, Biosimilars should take an increasingly important role as a powerful force driving down the cost of healthcare in the US and elsewhere or enabling more patients to gain access to some of the most complex biologics: eight therapies among the world’s Top 10 could face biosimilar competition, mostly in the field of inflammation.
20/06/2017
Our Convictions
This section develops our central scenario and our main convictions. It highlights the main orientations of our asset allocation and presents the strategies that characterize the structure of our portfolios:bond portfolios, equity portfolios and diversified portfolios.
09/06/2017
Cross Asset Investment Strategy - 06-2017
Find the latest edition of the monthly publication of our Research Team.
09/06/2017
UK Elections on 8th June - A key step ahead of Brexit
UK Elections on 8th June - A key step ahead of Brexit
19/05/2017
The Engagement Report 2016 is online
For the fourth consecutive year, Amundi publishes its Engagement Report.